Literature DB >> 29169471

Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia: Too Good to Be True?

Theodore E Warkentin1.   

Abstract

Entities:  

Keywords:  fondaparinux; heparin-induced thrombocytopenia

Mesh：

Substances：

Year:  2017        PMID： 29169471     DOI： 10.1016/j.jacc.2017.09.1098

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

Review 1.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Gowthami M Arepally; Beng H Chong; Douglas B Cines; Andreas Greinacher; Yves Gruel; Lori A Linkins; Stephen B Rodner; Sixten Selleng; Theodore E Warkentin; Ashleigh Wex; Reem A Mustafa; Rebecca L Morgan; Nancy Santesso
Journal:  Blood Adv       Date:  2018-11-27

3.  A "Catastrophic" Heparin-Induced Thrombocytopenia.

Authors:  D Barcellona; M Melis; G Floris; A Mameli; A Muroni; G Defazio; F Marongiu
Journal:  Case Rep Med       Date:  2020-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.